This review looked at how the HPV vaccine works for adults between the ages of 18 and 45. The researchers focused on whether the vaccine could prevent infections, keep viruses from staying in the body, and stop related issues like cervical lesions and genital warts.
The findings show a link between the vaccine and lower rates of HPV infection and viral persistence. However, when looking at high-grade cervical lesions, the results were not consistent across different studies. Because these estimates varied so much, it is hard to say exactly how effective the vaccine is for those specific types of lesions.
Because this was a narrative review, the findings are based on existing reports rather than a single new trial. While there is an association between vaccination and fewer infections, the evidence for preventing all related diseases is not uniform. Patients should talk to their doctor about how these results apply to their personal health needs.
Common questions
Does the HPV vaccine work for adults?
This review looked at adults between the ages of 18 and 45. It found that some associations exist between the HPV vaccine and a reduction in both HPV infection and viral persistence. These findings help inform how the vaccine might be used in adult immunization programs.
Can the vaccine prevent cervical lesions?
The study looked at high-grade cervical lesions, known as CIN2+. However, the results for these specific lesions varied widely across different studies. Because of this variation, a clear conclusion on its effectiveness for these specific lesions was not established.
Does the vaccine help with other HPV issues?
The review looked at several outcomes, including anogenital warts and precancerous cervical lesions. While it showed a link to reduced infection and viral persistence, you should speak with a healthcare provider to understand how these findings apply to your specific health situation.
